Clinical Trials · NCT06435702
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Peking University Third Hospital
- Enrollment
- 108
- Start date
- Jun 2024
- Locations
- 1 site, China
- Primary endpoint
- Time to CRPC